GSK stock edges higher in London as investors size up the next catalyst week
GSK shares rose 0.4% to 2,173 pence in early London trading Monday, near recent highs. Investors are watching the Feb. 19 ex-dividend date and recent moves by new CEO Luke Miels, including a push for business development and updates on vaccine filings in China.